Saxagliptin + metformin

Trade Name:

Komboglyze

Manufacturer/Distributor:

Bristol-Myers Squibb Canada

www.bmscanada.ca

Classification:

Oral antihyperglycemic agent

DPP-4 inhibitor

Incretin enhancer

ATC Class:

A10BD10 - metformin and saxagliptin

Status:

active

Notice of Compliance (yyyy/mm/dd):

2012/07/09

Date Marketed in Canada (yyyy/mm/dd):

2013/04/25

Presentation:

Tablet: 2.5 mg saxagliptin + 500 mg metformin. DIN: 02389169

Tablet: 2.5 mg saxagliptin + 850 mg metformin. DIN: 02389177

Tablet: 2.5 mg saxagliptin + 1000 mg metformin. DIN: 02389185

Comments:

For use as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with saxagliptin and metformin or who are inadequately controlled on metformin alone. It is also indicated for use in combination with premixed or long/intermediate acting insulin as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with saxagliptin, metformin and premixed or long/intermediate acting insulin or who are inadequately controlled on metformin and premixed or long/intermediate acting insulin alone.

Keywords:

saxagliptin

Keywords:

metformin

Keywords:

diabetes

Access:

public

Back to:

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database

A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)

Generic Name	Common Trade Name(s)	Classification	Date Marketed in Canada (yyyy/mm/dd)
Abatacept	Orencia	Co-stimulation modulator for rheumatoid arthritis	2006/09
Abemaciclib	Verzenio	Protein kinase inhibitor	2019/07/03
Abiraterone	Zytiga	Androgen biosynthesis inhibitor	2011/08/08
Acamprosate	Campral	Alcohol abstinence aid	2007/03
Aclidinium + formoterol	Duaklir Genuair	Bronchodilator combination - LAMA plus LABA	2015/07/09
Aclidinium bromide	Tudorza Genuair	Bronchodilator	2013-09
Adapalene + benzoyl peroxide	Tactuo	Acne therapy	2011/04
Adefovir dipivoxil	Hepsera	Antiviral agent	2006/10
Afatinib	Giotrif	Protein kinase inhibitor	2014/05/28
Albiglutide	Eperzan	Antihyperglycemic agent	2016/02/19
Alendronate	Fosamax	Bone resorption inhibitor	2011/03
Alglucosidase alfa	Myozyme	Enzyme replacement therapy	2007/04
Aliskiren and hydrochlorothiazide	Rasilez HCT	Renin inhibitor and diuretic	2009/09
Alitretinoin	Toctino	Immunomodulator, antiinflammatory agent	2010/10/19
Alogliptin	Nesina	Oral antihyperglycemic agent	2014/10/08
Alogliptin + metformin	Kazano	Oral antihyperglycemic agent	2014/10/08
Alpelisib	Piqray	Antineoplastic agent	2020/03/11
Aluminum chloride hexahydrate	Hydrosal gel	Antiperspirant
Aminophylline	Phyllocontin	Bronchodilator	2010
Apalutamide	Erleada	Anti-androgen	2018/07/27
Apixaban	Eliquis	Anticoagulant	2012/03
Apomorphine	Movapo	Nonergot-derivative dopamine receptor agonist	2018/04/xx
Apomorphine	Kynmobi	Nonergot-derivative dopamine receptor agonist	2020/06/12
Apremilast	Otezla	Immunosuppressant agent	2014/12/08
Aripiprazole	Abilify	Antipsychotic agent	2009/07/03
ASA + Meprobamate + Codeine + Caffeine	282 MEP	Narcotic analgesic
Asenapine	Saphris	Atypical antipsychotic	2012/03/16
Asunaprevir	Sunvepra	Antiviral agent	2016/04/22
Avelumab	Bavencio	Antineoplastic agent	2017/12/18
Axicabtagene ciloleucel	Yescarta	Antineoplastic agent	2019/11/27
Axitinib	Inlyta	Anti-tumor agent	2012/09
Azacitidine	Vidaza	Antineoplastic agent	2009/12/07
Azelastine + fluticasone	Dymista	Antihistamine and corticosteroid agent	2015/10/22
Azilsartan	Edarbi	Antihypertensive agent	2013/03/27
Azilsartan + chlorthalidone	Edarbyclor	Antihypertensive agent	2013/03/27
Azithromycin dihydrate	Zmax SR	Antibiotic	2010/10/29